Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Adipokine genes and prostate cancer risk.

Moore SC, Leitzmann MF, Albanes D, Weinstein SJ, Snyder K, Virtamo J, Ahn J, Mayne ST, Yu H, Peters U, Gunter MJ.

Int J Cancer. 2009 Feb 15;124(4):869-76. doi: 10.1002/ijc.24043.

PMID:
19035456
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Genetic polymorphisms in adipokine genes and the risk of obesity: a systematic review and meta-analysis.

Yu Z, Han S, Cao X, Zhu C, Wang X, Guo X.

Obesity (Silver Spring). 2012 Feb;20(2):396-406. doi: 10.1038/oby.2011.148. Epub 2011 Jun 9. Review.

PMID:
21660081
[PubMed - indexed for MEDLINE]
3.

Obesity, adipokines, and prostate cancer in a prospective population-based study.

Baillargeon J, Platz EA, Rose DP, Pollock BH, Ankerst DP, Haffner S, Higgins B, Lokshin A, Troyer D, Hernandez J, Lynch S, Leach RJ, Thompson IM.

Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1331-5.

PMID:
16835332
[PubMed - indexed for MEDLINE]
Free Article
4.

Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men.

Woodson K, Tangrea JA, Pollak M, Copeland TD, Taylor PR, Virtamo J, Albanes D.

Cancer Res. 2003 Jul 15;63(14):3991-4.

PMID:
12873996
[PubMed - indexed for MEDLINE]
Free Article
5.

Prostate cancer risk in relation to insulin-like growth factor (IGF)-I and IGF-binding protein-3: A nested case-control study in large scale cohort study in Japan.

Mikami K, Ozasa K, Nakao M, Miki T, Hayashi K, Watanabe Y, Mori M, Sakauchi F, Washio M, Kubo T, Suzuki K, Wakai K, Nakachi K, Tajima K, Ito Y, Inaba Y, Tamakoshi A; JACC Study Group.

Asian Pac J Cancer Prev. 2009 Dec;10 Suppl:57-61.

PMID:
20553083
[PubMed - indexed for MEDLINE]
Free Article
6.

IGF-1 and IGFBP-3 gene variants influence on serum levels and prostate cancer risk in African-Americans.

Hernandez W, Grenade C, Santos ER, Bonilla C, Ahaghotu C, Kittles RA.

Carcinogenesis. 2007 Oct;28(10):2154-9. Epub 2007 Aug 27.

PMID:
17724372
[PubMed - indexed for MEDLINE]
Free Article
7.

Genetic variation in adipokine genes and risk of colorectal cancer.

Pechlivanis S, Bermejo JL, Pardini B, Naccarati A, Vodickova L, Novotny J, Hemminki K, Vodicka P, Försti A.

Eur J Endocrinol. 2009 Jun;160(6):933-40. doi: 10.1530/EJE-09-0039. Epub 2009 Mar 9. Erratum in: Eur J Endocrinol. 2009 Jul;161(1):211.

PMID:
19273568
[PubMed - indexed for MEDLINE]
Free Article
8.

Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE II.

Wang MH, Helzlsouer KJ, Smith MW, Hoffman-Bolton JA, Clipp SL, Grinberg V, De Marzo AM, Isaacs WB, Drake CG, Shugart YY, Platz EA.

Prostate. 2009 Jun 1;69(8):874-85. doi: 10.1002/pros.20933.

PMID:
19267370
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Common polymorphisms in the adiponectin and its receptor genes, adiponectin levels and the risk of prostate cancer.

Dhillon PK, Penney KL, Schumacher F, Rider JR, Sesso HD, Pollak M, Fiorentino M, Finn S, Loda M, Rifai N, Mucci LA, Giovannucci E, Stampfer MJ, Ma J.

Cancer Epidemiol Biomarkers Prev. 2011 Dec;20(12):2618-27. doi: 10.1158/1055-9965.EPI-11-0434. Epub 2011 Sep 29.

PMID:
21960694
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study.

Stattin P, Bylund A, Rinaldi S, Biessy C, Déchaud H, Stenman UH, Egevad L, Riboli E, Hallmans G, Kaaks R.

J Natl Cancer Inst. 2000 Dec 6;92(23):1910-7.

PMID:
11106682
[PubMed - indexed for MEDLINE]
Free Article
11.

Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.

Douglas JB, Silverman DT, Pollak MN, Tao Y, Soliman AS, Stolzenberg-Solomon RZ.

Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2298-306. doi: 10.1158/1055-9965.EPI-10-0400. Epub 2010 Aug 10.

PMID:
20699371
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans.

Zheng SL, Sun J, Cheng Y, Li G, Hsu FC, Zhu Y, Chang BL, Liu W, Kim JW, Turner AR, Gielzak M, Yan G, Isaacs SD, Wiley KE, Sauvageot J, Chen HS, Gurganus R, Mangold LA, Trock BJ, Gronberg H, Duggan D, Carpten JD, Partin AW, Walsh PC, Xu J, Isaacs WB.

J Natl Cancer Inst. 2007 Oct 17;99(20):1525-33. Epub 2007 Oct 9.

PMID:
17925536
[PubMed - indexed for MEDLINE]
Free Article
13.

Vitamin D receptor gene polymorphisms, insulin-like growth factors, and prostate cancer risk: a population-based case-control study in China.

Chokkalingam AP, McGlynn KA, Gao YT, Pollak M, Deng J, Sesterhenn IA, Mostofi FK, Fraumeni JF Jr, Hsing AW.

Cancer Res. 2001 Jun 1;61(11):4333-6.

PMID:
11389055
[PubMed - indexed for MEDLINE]
Free Article
14.

Leptin and leptin receptor genotypes and colon cancer: gene-gene and gene-lifestyle interactions.

Slattery ML, Wolff RK, Herrick J, Caan BJ, Potter JD.

Int J Cancer. 2008 Apr 1;122(7):1611-7.

PMID:
18059035
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Serum insulin, glucose, indices of insulin resistance, and risk of prostate cancer.

Albanes D, Weinstein SJ, Wright ME, Männistö S, Limburg PJ, Snyder K, Virtamo J.

J Natl Cancer Inst. 2009 Sep 16;101(18):1272-9. doi: 10.1093/jnci/djp260. Epub 2009 Aug 21.

PMID:
19700655
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancer.

Severi G, Morris HA, MacInnis RJ, English DR, Tilley WD, Hopper JL, Boyle P, Giles GG.

Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1137-41.

PMID:
16775172
[PubMed - indexed for MEDLINE]
Free Article
17.

Plasma insulin-like growth factor-1 and binding protein-3 and subsequent risk of prostate cancer in the PSA era.

Platz EA, Pollak MN, Leitzmann MF, Stampfer MJ, Willett WC, Giovannucci E.

Cancer Causes Control. 2005 Apr;16(3):255-62.

PMID:
15947877
[PubMed - indexed for MEDLINE]
18.

Insulin-like growth factors and prostate cancer: a population-based case-control study in China.

Chokkalingam AP, Pollak M, Fillmore CM, Gao YT, Stanczyk FZ, Deng J, Sesterhenn IA, Mostofi FK, Fears TR, Madigan MP, Ziegler RG, Fraumeni JF Jr, Hsing AW.

Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):421-7.

PMID:
11352850
[PubMed - indexed for MEDLINE]
Free Article
19.

PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3).

Dossus L, Kaaks R, Canzian F, Albanes D, Berndt SI, Boeing H, Buring J, Chanock SJ, Clavel-Chapelon F, Feigelson HS, Gaziano JM, Giovannucci E, Gonzalez C, Haiman CA, Hallmans G, Hankinson SE, Hayes RB, Henderson BE, Hoover RN, Hunter DJ, Khaw KT, Kolonel LN, Kraft P, Ma J, Le Marchand L, Lund E, Peeters PH, Stampfer M, Stram DO, Thomas G, Thun MJ, Tjonneland A, Trichopoulos D, Tumino R, Riboli E, Virtamo J, Weinstein SJ, Yeager M, Ziegler RG, Cox DG.

Carcinogenesis. 2010 Mar;31(3):455-61. doi: 10.1093/carcin/bgp307. Epub 2009 Dec 4.

PMID:
19965896
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians.

Schumacher FR, Cheng I, Freedman ML, Mucci L, Allen NE, Pollak MN, Hayes RB, Stram DO, Canzian F, Henderson BE, Hunter DJ, Virtamo J, Manjer J, Gaziano JM, Kolonel LN, Tjønneland A, Albanes D, Calle EE, Giovannucci E, Crawford ED, Haiman CA, Kraft P, Willett WC, Thun MJ, Le Marchand L, Kaaks R, Feigelson HS, Bueno-de-Mesquita HB, Palli D, Riboli E, Lund E, Amiano P, Andriole G, Dunning AM, Trichopoulos D, Stampfer MJ, Key TJ, Ma J.

Hum Mol Genet. 2010 Aug 1;19(15):3089-101. doi: 10.1093/hmg/ddq210. Epub 2010 May 19.

PMID:
20484221
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk